All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Pharming Group N.V. revenue reports

Pharming Group N.V. financial reports, Pharming Group N.V. annual revenue in 2024. When does Pharming Group N.V. report revenue?
Add to widgets
Added to widgets

Pharming Group N.V. total revenue, net income and dynamics of changes in Euro today

Pharming Group N.V. revenue for the past few reporting periods. The dynamics of net revenue of Pharming Group N.V. rose. The change amounted to 5 220 000 €. The dynamics of net revenue is shown in comparison with the previous report. The dynamics of Pharming Group N.V. net income went down. The change was -2 203 000 €. The financial graph of Pharming Group N.V. shows the values and changes of such indicators: total assets, net income, net revenue. Information on Pharming Group N.V. net income on the chart on this page is drawn in blue bars. The value of Pharming Group N.V. assets on the online chart is displayed in green bars.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021 41 262 000 € -3.393 % ↓ 4 848 000 € -29.278 % ↓
31/03/2021 36 042 000 € +2.32 % ↑ 7 051 000 € +4.63 % ↑
31/12/2020 50 980 000 € +38.34 % ↑ 7 439 000 € -43.971 % ↓
30/09/2020 46 121 000 € +1.54 % ↑ 7 453 000 € -28.761 % ↓
30/09/2019 45 423 000 € - 10 462 000 € -
30/06/2019 42 711 000 € - 6 855 000 € -
31/03/2019 35 224 000 € - 6 739 000 € -
31/12/2018 36 850 000 € - 13 277 000 € -
Show:
to

Pharming Group N.V. financial report charts

The latest dates of Pharming Group N.V. financial statements available online: 31/12/2018, 31/03/2021, 30/06/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest financial report of Pharming Group N.V. is available online for such a date - 30/06/2021. Gross profit Pharming Group N.V. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Pharming Group N.V. is 37 403 000 €

Pharming Group N.V. quarterly report dates

Cost of revenue Pharming Group N.V. is the total cost of producing and distributing of products and services of a company. Cost of revenue Pharming Group N.V. is 3 859 000 € Total revenue Pharming Group N.V. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Pharming Group N.V. is 41 262 000 € Operating income Pharming Group N.V. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Pharming Group N.V. is 9 023 000 €

Net income Pharming Group N.V. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Pharming Group N.V. is 4 848 000 € Current assets Pharming Group N.V. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Pharming Group N.V. is 211 137 000 € Total assets Pharming Group N.V. refers to the total amount of assets owned by a person or entity. Total assets Pharming Group N.V. is 346 231 000 €

30/06/2021 31/03/2021 31/12/2020 30/09/2020 30/09/2019 30/06/2019 31/03/2019 31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
37 403 000 € 32 035 000 € 45 073 000 € 41 285 000 € 40 101 000 € 37 175 000 € 29 804 000 € 30 514 000 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
3 859 000 € 4 007 000 € 5 907 000 € 4 836 000 € 5 322 000 € 5 536 000 € 5 420 000 € 6 336 000 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
41 262 000 € 36 042 000 € 50 980 000 € 46 121 000 € 45 423 000 € 42 711 000 € 35 224 000 € 36 850 000 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - 45 423 000 € 42 711 000 € 35 224 000 € 36 850 000 €
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
9 023 000 € 5 198 000 € 13 994 000 € 18 834 000 € 18 052 000 € 12 388 000 € 12 244 000 € 6 977 000 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
4 848 000 € 7 051 000 € 7 439 000 € 7 453 000 € 10 462 000 € 6 855 000 € 6 739 000 € 13 277 000 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
11 217 000 € 8 853 000 € 9 902 000 € 7 819 000 € 8 849 000 € 9 572 000 € 5 305 000 € 11 314 000 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
32 239 000 € 30 844 000 € 36 986 000 € 27 287 000 € 27 371 000 € 30 323 000 € 22 980 000 € 29 873 000 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
211 137 000 € 223 343 000 € 214 343 000 € 197 623 000 € 101 788 000 € 101 215 000 € 101 689 000 € 115 440 000 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
346 231 000 € 348 519 000 € 340 758 000 € 319 348 000 € 220 814 000 € 205 795 000 € 199 560 000 € 214 569 000 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
158 304 000 € 175 941 000 € 167 068 000 € 154 795 000 € 62 967 000 € 63 886 000 € 65 264 000 € 80 311 000 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 90 103 000 € 65 973 000 € 62 269 000 € 82 599 000 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 130 339 000 € 128 305 000 € 130 493 000 € 152 818 000 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 59.03 % 62.35 % 65.39 % 71.22 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
166 516 000 € 158 686 000 € 149 377 000 € 136 253 000 € 90 475 000 € 77 490 000 € 69 067 000 € 61 751 000 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - 22 227 000 € 15 045 000 € 9 977 000 € 14 352 000 €

Last revenue report of Pharming Group N.V. was 30/06/2021. According to last financial report total revenue in Pharming Group N.V. was 41 262 000 Euro and changed by -3.393% since last year. Net income in Pharming Group N.V. was 4 848 000 € in last quartal, net income changes to -29.278%.

Current cash Pharming Group N.V. - the sum of all of the cash a company has on the date of report. Current cash Pharming Group N.V. is 158 304 000 €

Pharming Group N.V. stocks data

Pharming Group N.V. financials